Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
Evofem Biosciences NASDAQ EVFM
$0.02 0.0020 13.33%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 17 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

873.72M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
938.95M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-0.39
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
58.25B
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-76.56 %
Upcoming events Evofem Biosciences All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Evofem Biosciences

Stock analysis Evofem Biosciences

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
19.55 14.86
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-12.17 3.70
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-12.88 9.68
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-0.89 -0.17
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-62.25 11.19

Price change Evofem Biosciences per year

0.65$ 5.53$
Min Max

Summary analysis Evofem Biosciences

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Evofem Biosciences

Revenue and net income Evofem Biosciences

All parameters
Stock news Evofem Biosciences All news
23 September 2022 в 16:27

Evofem Biosciences Gets U.S. Patent for Phexxi Composition

23 September 2022 в 16:27

Evofem Biosciences Gets U.S. Patent for Phexxi Composition

16 September 2022 в 13:30

Evofem Biosciences Successfully Executes Restructuring of Debt

16 September 2022 в 13:30

Evofem Biosciences Successfully Executes Restructuring of Debt

2 June 2022 в 16:16

Evofem Biosciences's Phexxi Gets Extended Shelf Life From FDA

2 June 2022 в 16:16

Evofem Biosciences's Phexxi Gets Extended Shelf Life From FDA

20 May 2022 в 16:30

Evofem Biosciences Prices Public Offering Worth $26.6 Million

20 May 2022 в 16:25

Evofem Biosciences Prices Public Offering Worth $26.6 Million

20 May 2022 в 02:00

Evofem Biosciences Down 30% After Hours; Plans Stock and Warrant Sale

20 May 2022 в 01:55

Evofem Biosciences Down 30% After Hours; Plans Stock and Warrant Sale

14 January 2022 в 15:00

Evofem Biosciences stock price target raised to $3 from $2 at Stifel Nicolaus

27 August 2021 в 13:35

Evofem Biosciences Gets Deficiency Letter From Nasdaq

27 August 2021 в 13:35

Evofem Biosciences Gets Deficiency Letter From Nasdaq

About company Evofem Biosciences

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. It has a collaboration agreement with National Community Oncology Dispensing Association, Inc. to educate oncology community about Phexxi. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Address:
12400 High Bluff Drive, San Diego, CA, United States, 92130
Company name: Evofem Biosciences
Issuer ticker: EVFM
ISIN: US30048L1044
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2018-01-17
Sector: Healthcare
Industry: Biotechnology
Site: https://www.evofem.com

On which stock exchange are Evofem Biosciences (EVFM) stocks traded?

Evofem Biosciences (EVFM) stocks are traded on NASDAQ.

What is the ticker of Evofem Biosciences stocks (EVFM)?

The stock ticker of Evofem Biosciences’s stocks or in other words, the code is EVFM. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Evofem Biosciences (EVFM) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Evofem Biosciences (EVFM) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Evofem Biosciences (EVFM) stocks traded?

Evofem Biosciences (EVFM) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Evofem Biosciences (EVFM) stocks today?

The current price of Evofem Biosciences stocks on 25.04.2024 is 0.015 dollars. per share.

What is the dynamics of Evofem Biosciences (EVFM) stocks from the beginning of the year?

Evofem Biosciences (EVFM) quotes have increased by -75% from the beginning of the year up to 0.015 dollars. per 1 stocks.

How much did Evofem Biosciences (EVFM) stocks increase in апреле 2024?

This month Evofem Biosciences (EVFM) quotes have increased by -26.47% to 0.015 dollars. per share.

How much are Evofem Biosciences (EVFM) stocks worth?

Today, on October, 25.04.2024 Evofem Biosciences’s (EVFM) stocks cost 0.015 dollars..

What is the market capitalization of Evofem Biosciences (EVFM)?

Capitalization is the market value of Evofem Biosciences (EVFM) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 25.04.2024, the market capitalization of Evofem Biosciences (EVFM) is estimated at about 873721185 dollars.